Clin2
NCT07849803Possibly a fitNot yet recruiting

Eye drops for dry eyes and nerve pain

Ocular PainDry Eye

Part of Eyes & vision, Pain clinical trials.

This trial tests a new eye drop (acoltre mon) to see if it helps people who have both dry eyes and nerve-related eye pain. The drops may increase tear production and reduce burning or light sensitivity.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
28 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • Your eye doctor has confirmed you have low tear production (measured with a special test).
  • You have had eye pain or burning that feels nerve-related for at least 3 months.
  • You are willing to stop using other eye drops (except artificial tears or serum tears) for about 8 days before the trial starts.
  • You must not have any active eye infection, eye surgery in the past 3 months, or be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07848373Not yet recruiting· Phase 4
Dry eye treatment for contact lens wearers

This trial tests a new eye drop for people who wear contact lenses and have dry eyes. The treatment may help reduce dryness and improve comfort while wearing lenses.

NCT07625124Not yet recruiting· Phase 2
Eye drop for dry eye disease

This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.

NCT07659626Recruiting
Long-term effects of Acoltremon for dry eye disease

This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.

Louisville, Kentucky
NCT06964269Recruiting· Phase 4
Acthar Gel for dry eye and autoimmune disease

This trial tests a new injectable medicine, Acthar Gel, for moderate to severe dry eye and eye pain linked to autoimmune disease. It aims to see if the drug can relieve these symptoms safely.

Nashville, Tennessee
NCT06360133Recruiting· Phase 3
New eye drop for dry eye disease

This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.

Shanghai, Shanghai Municipality
NCT07502378Recruiting· Phase 4
Eye drops for dry eye in early neurotrophic keratopathy

This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.

Tampa, Florida

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.